|
Volumn 26, Issue 4, 2002, Pages 409-410
|
Dendritic cell generation for leukemia immunotherapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
CALCIUM IONOPHORE;
CD40 LIGAND;
CYTOKINE;
FMS LIKE TYROSINE KINASE 3 LIGAND;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR;
INTERLEUKIN 4;
LEUKEMIA ANTIGEN;
LIGAND;
STEM CELL FACTOR;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
ACUTE GRANULOCYTIC LEUKEMIA;
ACUTE LYMPHOCYTIC LEUKEMIA;
ANTIGEN PRESENTING CELL;
CELL ACTIVITY;
CELL LINE;
CELL MATURATION;
CELL VIABILITY;
CELLULAR IMMUNITY;
CHRONIC MYELOID LEUKEMIA;
CHRONIC MYELOMONOCYTIC LEUKEMIA;
DENDRITIC CELL;
DRUG EFFICACY;
HUMAN;
IMMUNOREGULATION;
IMMUNOTHERAPY;
LEUKEMIA;
LYMPHOCYTE DIFFERENTIATION;
MAJOR HISTOCOMPATIBILITY COMPLEX;
NOTE;
PHENOTYPE;
PRIORITY JOURNAL;
T LYMPHOCYTE ACTIVATION;
TUMOR REGRESSION;
VACCINATION;
ACUTE DISEASE;
ANTIGEN PRESENTATION;
ANTIGENS, NEOPLASM;
CYTOTOXICITY, IMMUNOLOGIC;
DENDRITIC CELLS;
HUMANS;
IMMUNOTHERAPY, ADOPTIVE;
LEUKEMIA;
|
EID: 0036166236
PISSN: 01452126
EISSN: None
Source Type: Journal
DOI: 10.1016/S0145-2126(01)00137-0 Document Type: Note |
Times cited : (2)
|
References (15)
|